Oct 3, 2026 · 41 min
Seven Nobel contenders test the limits of prize recognition
2026 Nobel Prize Predictions: Medicine, Physics & Chemistry (EP 60)
The predictions reveal how Nobel committees might honor discoveries built by large, collaborative fields when each prize can recognize only three people.
- 1The medicine shortlist spans transformative treatments, neural control, and retina imaging, with each field raising difficult attribution questions.
- 2Physics predictions connect foundational quantum effects with atomic-scale measurement, linking abstract theory to powerful experimental tools.
- 3Chemistry candidates show how catalytic reactions and cellular phase separation have reshaped drug discovery and biological understanding.
Don't miss
The GLP-1 prediction crystallizes the episode’s central dilemma: a transformative treatment may involve more deserving contributors than the Nobel’s three-person limit allows.
The brief
Lester Nare and Krishna Rao open with the familiar Nobel phone-call drama, then frame seven predictions around a recurring problem: discoveries rarely belong to only three people.
Medicine ranges from GLP-1 drugs and optogenetics to optical coherence tomography, pairing major practical impact with unresolved questions about who deserves credit.
The physics section moves from the Aharonov–Bohm effect’s challenge to quantum intuition to atomic force microscopy’s ability to probe matter at near-atomic scales.
Chemistry turns to biomolecular condensates and Buchwald–Hartwig coupling, two very different advances that organize cellular chemistry and enable precise molecular design.
The standout tension is GLP-1 recognition: biology, discovery, and drug development all matter, but the Nobel rules leave room for only three recipients.
The hosts keep the preview deliberately brief so they can respond quickly when the Nobel announcements arrive, making attribution the episode’s central lens.